Indiva Ltd NDVA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NDVA is a good fit for your portfolio.
News
-
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations
-
Indiva to Report Fourth Quarter and Full Year Results Pre-Market on Thursday, April 25, 2024
-
Indiva Provides Update on SNDL Loan and Retains Financial Advisor To Evaluate Strategic Alternatives
-
Indiva Announces Second Private Placement Under the Listed Issuer Financing Exemption up to $4,094,000
-
Indiva Announces Closing of the First Tranche of Life Offering & Provides Update on Previously Announced Private Placement
-
Indiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 Million
Trading Information
- Previous Close Price
- CAD 0.08
- Day Range
- CAD 0.07–0.07
- 52-Week Range
- CAD 0.02–0.13
- Bid/Ask
- CAD 0.06 / CAD 0.07
- Market Cap
- CAD 12.69 Mil
- Volume/Avg
- 166,684 / 91,895
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.33
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Indiva Ltd sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, the company produces and distributes award-winning cannabis products nationally, including Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Sapphire Cannabis Salt, as well as capsules, pre-rolls and premium flower under the INDIVA and Artisan Batch brands.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 142
- Website
- https://www.indiva.com
Valuation
|
Metric
|
NDVA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 37.63 |
Price/Sales | 0.33 |
Price/Cash Flow | — |
Price/Earnings
NDVA
Financial Strength
|
Metric
|
NDVA
|
|---|---|
Quick Ratio | 0.58 |
Current Ratio | 0.85 |
Interest Coverage | −0.52 |
Quick Ratio
NDVA
Profitability
|
Metric
|
NDVA
|
|---|---|
Return on Assets (Normalized) | −15.40% |
Return on Equity (Normalized) | −356.26% |
Return on Invested Capital (Normalized) | −5.35% |
Return on Assets
NDVA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xlyfnyggzh | Hzyy | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Tmsqxjcyrr | Dfdmrzf | $70.8 Bil | |
HLN
| Haleon PLC ADR | Gsvvlfrys | Fdrj | $38.2 Bil | |
VTRS
| Viatris Inc | Qlqlyyyg | Kvwwg | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Yyyzlqhy | Qqhj | $12.5 Bil | |
CTLT
| Catalent Inc | Sbvsrtks | Vgpwyr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Lxlvhzmkz | Vwnm | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Gvrrmfhmx | Pvvz | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xwczrtxg | Qytkt | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Qxjqpnlkhs | Ljyg | $2.9 Bil |